Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Introducing a New Series: Immunotherapy Facts and Hopes.

Melero I, Sznol M, Tessmer MS, Whiteside TL, Wolchok JD.

Clin Cancer Res. 2018 Apr 15;24(8):1773-1774. doi: 10.1158/1078-0432.CCR-18-0408. Epub 2018 Feb 23. No abstract available.

2.

AACR Cancer Progress Report 2017: Harnessing Research Discoveries to Save Lives.

Tessmer MS, Flaherty KT.

Clin Cancer Res. 2017 Sep 15;23(18):5325. doi: 10.1158/1078-0432.CCR-17-2302. No abstract available.

3.

AACR Cancer Progress Report 2016: Improving Lives Through Research.

Tessmer MS, Anderson KC.

Clin Cancer Res. 2016 Oct 1;22(19):4759. Epub 2016 Oct 2. No abstract available.

4.

Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.

Chan IH, Jain R, Tessmer MS, Gorman D, Mangadu R, Sathe M, Vives F, Moon C, Penaflor E, Turner S, Ayanoglu G, Chang C, Basham B, Mumm JB, Pierce RH, Yearley JH, McClanahan TK, Phillips JH, Cua DJ, Bowman EP, Kastelein RA, LaFace D.

Mucosal Immunol. 2014 Jul;7(4):842-56. doi: 10.1038/mi.2013.101. Epub 2013 Nov 27.

PMID:
24280935
5.

Salivary gland NK cells are phenotypically and functionally unique.

Tessmer MS, Reilly EC, Brossay L.

PLoS Pathog. 2011 Jan 13;7(1):e1001254. doi: 10.1371/journal.ppat.1001254.

6.

NKT cell immune responses to viral infection.

Tessmer MS, Fatima A, Paget C, Trottein F, Brossay L.

Expert Opin Ther Targets. 2009 Feb;13(2):153-62. doi: 10.1517/14712590802653601 . Review.

7.

Cutting edge: Priming of NK cells by IL-18.

Chaix J, Tessmer MS, Hoebe K, Fuséri N, Ryffel B, Dalod M, Alexopoulou L, Beutler B, Brossay L, Vivier E, Walzer T.

J Immunol. 2008 Aug 1;181(3):1627-31.

8.

NK cell-like behavior of Valpha14i NK T cells during MCMV infection.

Wesley JD, Tessmer MS, Chaukos D, Brossay L.

PLoS Pathog. 2008 Jul 18;4(7):e1000106. doi: 10.1371/journal.ppat.1000106.

9.

A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo.

Guia S, Cognet C, de Beaucoudrey L, Tessmer MS, Jouanguy E, Berger C, Filipe-Santos O, Feinberg J, Camcioglu Y, Levy J, Al Jumaah S, Al-Hajjar S, Stephan JL, Fieschi C, Abel L, Brossay L, Casanova JL, Vivier E.

Blood. 2008 May 15;111(10):5008-16. doi: 10.1182/blood-2007-11-122259. Epub 2008 Mar 4.

10.

A Y chromosome-linked factor impairs NK T development.

Wesley JD, Tessmer MS, Paget C, Trottein F, Brossay L.

J Immunol. 2007 Sep 15;179(6):3480-7.

11.

KLRG1 binds cadherins and preferentially associates with SHIP-1.

Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, Brossay L.

Int Immunol. 2007 Apr;19(4):391-400. Epub 2007 Feb 16.

PMID:
17307799
12.

Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation.

Robbins SH, Tessmer MS, Van Kaer L, Brossay L.

Eur J Immunol. 2005 Mar;35(3):757-65.

13.

Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection.

Robbins SH, Tessmer MS, Mikayama T, Brossay L.

J Immunol. 2004 Jul 1;173(1):259-66.

Supplemental Content

Loading ...
Support Center